Atlas Trials

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Clinical trial NCT05240521 · UNKNOWN

Trial details

NCT number
NCT05240521
Sponsor
Devintec Sagl
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Irritable Bowel Syndrome With Constipation (IBS-C)
Start date
2021-11-01
Primary completion
2022-08-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.